Infant Bacterial Therapeutics AB (publ) Net Asset Quality Index
Infant Bacterial Therapeutics AB (publ) net asset quality index. Infant Bacterial Therapeutics AB (publ) (IBT-B) has a Net Asset Quality Index of 69.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr178.23 Million minus total liabilities of Skr53.87 Million yields net assets of Skr124.36 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is Infant Bacterial Therapeutics AB (publ)'s book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Infant Bacterial Therapeutics AB (publ) (2013–2024)
Net asset quality index of Infant Bacterial Therapeutics AB (publ) from 2013 to 2024. This chart shows how Infant Bacterial Therapeutics AB (publ)'s Net Asset Quality Index has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the index stands at 69.8%, representing net assets of Skr124.36 Million against total assets of Skr178.23 Million SEK. Check how tangible is Infant Bacterial Therapeutics AB (publ)'s equity to evaluate the tangible quality of the company's equity base.
Infant Bacterial Therapeutics AB (publ) Net Asset Quality Index by Year (2013–2024)
Infant Bacterial Therapeutics AB (publ) net asset quality index by year from 2013 to 2024. The table below presents the year-by-year Net Asset Quality Index for Infant Bacterial Therapeutics AB (publ) from 2013 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Infant Bacterial Therapeutics AB (publ) (IBT-B) total market value.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 71.1% | Skr170.26 Million | Skr239.57 Million | Skr69.30 Million | ▼ -15.8 pp |
| 2023 | 86.9% | Skr305.15 Million | Skr351.33 Million | Skr46.18 Million | ▼ -8.0 pp |
| 2022 | 94.9% | Skr331.71 Million | Skr349.62 Million | Skr17.91 Million | ▼ -1.9 pp |
| 2021 | 96.8% | Skr395.25 Million | Skr408.48 Million | Skr13.22 Million | ▼ -1.0 pp |
| 2020 | 97.7% | Skr440.15 Million | Skr450.32 Million | Skr10.16 Million | ▼ -0.7 pp |
| 2019 | 98.5% | Skr510.40 Million | Skr518.27 Million | Skr7.88 Million | ▼ -0.3 pp |
| 2018 | 98.8% | Skr556.72 Million | Skr563.37 Million | Skr6.65 Million | ▲ +2.6 pp |
| 2017 | 96.2% | Skr168.37 Million | Skr175.02 Million | Skr6.65 Million | ▲ +0.6 pp |
| 2016 | 95.6% | Skr105.23 Million | Skr110.11 Million | Skr4.88 Million | ▲ +4.9 pp |
| 2015 | 90.6% | Skr74.81 Million | Skr82.54 Million | Skr7.73 Million | ▲ +14.7 pp |
| 2014 | 75.9% | Skr11.03 Million | Skr14.54 Million | Skr3.51 Million | ▼ -5.4 pp |
| 2013 | 81.3% | Skr1.05 Million | Skr1.29 Million | Skr240.70K | — |